RITA-MI2

RITA-MI 2 will conduct a phase 2b randomised double-blind placebo-controlled clinical trial to assess the impact of B cell depletion with the CD20 mAb rituximab drug on left ventricular dysfunction and cardiac remodelling after acute MI... The RITA-MI2 project First Annual Meeting took place on Tuesday 21st June 2022, on-line. 23 project members working for one of the 13 project partners gathered one afternoon to present and discuss about the project's first year and the next steps to be taken...

Primary location: Roubaix France